Skip to main content

CORRECTION article

Front. Aging Neurosci., 19 November 2024
Sec. Neurocognitive Aging and Behavior

Corrigendum: Association of trimethylamine oxide and its precursors with cognitive impairment: a systematic review and meta-analysis

\r\nCaiyi Long,&#x;Caiyi Long1,2Zihan Li,&#x;Zihan Li1,2Haoyue FengHaoyue Feng1Yayi Jiang,Yayi Jiang1,2Yueheng Pu,Yueheng Pu1,2Jiajing Tao,Jiajing Tao1,2Rensong Yue
Rensong Yue1*
  • 1Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
  • 2Chengdu University of Traditional Chinese Medicine, Chengdu, China

A Corrigendum on
Association of trimethylamine oxide and its precursors with cognitive impairment: a systematic review and meta-analysis

by Long, C., Li, Z., Feng, H., Jiang, Y., Pu, Y., Tao, J., and Yue, R. (2024). Front. Aging Neurosci. 16:1465457. doi: 10.3389/fnagi.2024.1465457

In the published article, there were errors in Figures 1, 2 and Tables 1, 2 as published. The order of the images in Figures 1 and 2 is reversed (the titles are correct, but the sequence of the images is incorrect). The first row of authors and references in Table 1, “Zhong (Zhong et al., 2021),” is incorrect. The correct citation should be “Zhu (Zhu et al., 2019)”. In Table 2, the references in the subgroup analysis for the group under 65, specifically “(Zhu et al., 2019; de Oliveira Otto et al., 2022; Wang et al., 2023)” are incorrect. They should be: “Zhong et al., 2021; Buawangpong et al., 2022; Xu et al., 2022.” The corrected Figures 1, 2 and Tables 1, 2 appear below.

Figure 1
www.frontiersin.org

Figure 1. Meta-analysis flow chart.

Figure 2
www.frontiersin.org

Figure 2. Odds ratio and 95% confidence interval of plasma trimethylamine oxide (TMAO) levels for cognitive impairment.

Table 1
www.frontiersin.org

Table 1. Basic characteristics.

Table 2
www.frontiersin.org

Table 2. Subgroup analysis.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: trimethylamine oxide, TMAO, circulating concentration, cognitive impairment, meta-analysis

Citation: Long C, Li Z, Feng H, Jiang Y, Pu Y, Tao J and Yue R (2024) Corrigendum: Association of trimethylamine oxide and its precursors with cognitive impairment: a systematic review and meta-analysis. Front. Aging Neurosci. 16:1519363. doi: 10.3389/fnagi.2024.1519363

Received: 29 October 2024; Accepted: 30 October 2024;
Published: 19 November 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Long, Li, Feng, Jiang, Pu, Tao and Yue. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Rensong Yue, songrenyue@cdutcm.edu.cn

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.